药物洗脱支架进展来自世界的数据分析

上传人:ra****d 文档编号:252656807 上传时间:2024-11-19 格式:PPT 页数:41 大小:8.64MB
返回 下载 相关 举报
药物洗脱支架进展来自世界的数据分析_第1页
第1页 / 共41页
药物洗脱支架进展来自世界的数据分析_第2页
第2页 / 共41页
药物洗脱支架进展来自世界的数据分析_第3页
第3页 / 共41页
点击查看更多>>
资源描述
,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,Concerns from Data Analysis in the Real-World,Shengshou Hu,M.D.,FACC,Department of Cardiac Surgery,Fu Wai Hospital,Beijing,China,DES 2007 UPDATE,Textbook&Theory,Drug-eluting Stents,Drug based therapeutics,Bare-metal Stents,Evolution of Cardiology,The Era of Drug-eluting Stents,More CAD patients prefer DES,I,prefer a less invasive,and more comfortable,therapy,The Era of Drug-eluting Stents,In the praise of DES,controversies never stop,The Era of Drug-eluting Stents,Safety and effectiveness:Remained unanswered,DES vs.BMS:Different results from different,RCTs,DES vs.CABG:3,RCTs,are ongoing,Editorials in NEJM on safety and efficacy of DES,The Era of Drug-eluting Stents,Restate the indication for DES,CYPHER:target lesion,30 mm,TAXUS:target lesion,28 mm,The Era of Drug-eluting Stents,What is the current status of DES,in the real-world?,The Era of Drug-eluting Stents,Too perfect designed to consider the difference among hospitals,physicians,Enrolled patients are relative healthier and exclude patients at high risk,Selection bias and uncontrolled,but can reflex the truth in the real-world,The Era of Drug-eluting Stents,DES in The Real-world,DES in The Real-world,DES in The Real-world,DES in The Real-world,A revolution brought by DES?,DES seems to be an optimal choice,*,DES reduces rate of stent restenosis compared with BMS.,*How much will DES benefit patients in the real-world?,*Can DES maintain its advantage compared with bypass in the,real-world?,DES in The Real-world,Data analysis from New York State Registry Database,DES in The Real-world,TRIAL DESIGN,Patients Statistical Analysis,17400 multi-vessel patients,DES n=9,963(at least one DES),CABG n=7,437,Follow-up,achieved in 99.0%,18 months,Propensity Analysis,Kaplan-Meier method,Cox proportional hazards models,DES in The Real-world,DES:18-mth rate of revascularization 30%,DES in The Real-world,18-mth Survival Analysis,CABG is superior to DES in term of,Total Mortality,DES in The Real-world,18-mth Survival,Analysis for MI,CABG is superior to DES in term of,Myocardial Infarction,DES in The Real-world,Subgroup Analysis,DES in The Real-world,CABG remains the standard of care for patients who require multivessel coronary revascularization.However,stents may be an alternative for patients at high risk for surgical complications or when an informed patient chooses a less invasive option.,DES in The Real-world,We would like to have used a longer follow-up period.Nevertheless,it would appear that the advantage of CABG would have persisted over the course of another year or two of follow-up,because our evidence of that tendency and because there is evidence of very late stent thrombosis in patients receiving DES.,DES in The Real-world,Data analysis from Fuwai Hospital Registry Database,Surgical volume by year,PCI volume by year,CABG Database:over 6000 cases,Stent Database:over 7000 cases,DES in The Real-world,TRIAL DESIGN,Patients 20042005)Statistical Analysis,3709 multi-vessel patients,CABG(n=1875),DES (n=1834),Follow-up,achieved in 98.0%,22.29.8 months,Propensity Analysis,Kaplan-Meier method,Cox proportional hazards models,Outcome measures,Total mortality,Repeated revascularization,Target-vessel revascularization,Q-wave myocardial Infarction,Data analysis from Fuwai Hospital Registry Database,DES in The Real-world,DES in The Real-world,Cumulative event rates during follow-up period,DES in The Real-world,Survival Analysis for Total Mortality,DES in The Real-world,Survival Analysis for Revascularization,DES in The Real-world,Logrank P 0.0001,Survival Analysis for TVR,DES in The Real-world,Survival Analysis,for Q-wave MI,DES in The Real-world,Favors,CABG,Favors DES,Subgroup Analysis:Cox model with PS stratification,DES in The Real-world,Conclusions,DES in The Real-world,CABG Patients were sicker,Being older,More co-morbidities,Poorer LV function,DES patients had higher rates of adverse outcomes,Total mortality,Revascularization,TVR,Q-wave MI,Discussion and Comment,What is the Differences between Bypass and PCI,PCI is targeted at the“culprit lesion or lesions.,CABG is directed at the vessel including lesions and future culprits.,March 2005,LIMAThe Golden Standard for LAD,10年通畅率95%,15年通畅率94,相当于DES 1年通畅率,Tatoulis,JTCVS,2004,Discussion and Comment,CABG,the standard method for coronary revascularization,Fuwai Database,Discussion and Comment,0.6%Mortality,Bypass surgery,On-pump CABG,Off-pump technique,Mimi-incision,Port-access,Fast tract anesthesia,Less Invasive,Excellent perioperative outcomes,Satisfactory long-term benefits,Becoming less invasive,The safety and effectiveness confirmed by 30 years of experiences,Concerns on DES appear,Discussion and Comment,Does DES bring a fundamental revolution to the PCI?,Reduce the rate of stent restenosis,Lead to early and very late stent thrombosis,Intensive post-DES anticoagulation bring new complications,Safety requiring longer-term follow-up,Discussion and Comment,Cover of LANCET Jan 2006,Why
展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 商业管理 > 商业计划


copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!